IL17A and type 2 diabetes mellitus: Specifically, IL-17-mediated inflammation has been implicated in the development of T2DM, with low-grade systemic inflammation identified as a key causative factor in T2DM pathogenesis, as evidenced by the studies of Velikova et al. (2021) and Hamid Akash et al. (2013).